Vice President, Regulatory Affairs

Ruth leads regulatory strategy for Cadence OTC.  She is a regulatory scientist with more than 25 years of experience in the biopharmaceutical industry covering a broad range of regulatory filings for innovative development and marketed products. Her experience in Regulatory Affairs includes strategy at biotech start-ups and larger pharma companies (Introgen, Avigen, CV Therapeutics, Gilead Sciences, and Astex Pharmaceuticals). Ruth holds a BA from Kalamazoo College and an MS from Oakland University.